BD has partnered with Techcyte to offer an artificial intelligence (AI)-enabled cervical cancer screening system, the companies announced Tuesday. Techcyte has developed a system to reduce the amount ...
Becton, Dickinson and Company (BD) announced that it has submitted a pre-market approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the BD Onclarity™ HPV Assay, its human ...
FRANKLIN LAKES, N.J., June 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVDD certification of the BD ...
FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...
BD Life Sciences-Diagnostic Systems, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of BD SurePath Direct to Slide. It is a liquid ...
FLORENCE, Italy--(BUSINESS WIRE)--BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today at EUROGIN 2013 that the ...
DURHAM, N.C., Dec. 7 BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to utilize ...
In a significant move to enhance cervical cancer screening accuracy and accessibility in India, Indira IVF collaborates with BD SurePath. This partnership is aimed at helping improve patient care in ...
Automated BD COR™ System Achieves CE-IVD Status; Now Available in Europe The BD COR™ System integrates and automates the complete molecular laboratory workflow from pre-analytical processing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results